Roberto Mina, MD

Roberto Mina, MD, is a hematologist with expertise in bone marrow transplantation and cellular therapies. He specializes in treating plasma cell disorders, including multiple myeloma, monoclonal gammopathies of undetermined significance (MGUS), amyloidosis and rare plasma cell dyscrasias such as plasma-cell leukemias and POEMS syndrome. Dr. Mina began practicing as an attending physician with Emory Healthcare in 2025.

He is an assistant professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Before joining Emory, he was on the faculty at the University of Turin in Italy.

Dr. Mina completed his medical education and hematology specialization at the University of Turin, followed by clinical and research fellowships in hematology. He also held a visiting scholarship at Winship Cancer Institute of Emory University in Atlanta.

His research focuses on plasma cell disorders, particularly multiple myeloma, including diagnosis, measurable residual disease (MRD) assessment and treatment of older patients. His work includes designing and implementing national and international clinical trials, especially early-phase studies, to explore novel agents, transplant strategies and advanced therapeutic sequencing.

Dr. Mina is a reviewer for journals such as Annals of Hematology and Neoplasma and has authored numerous peer-reviewed publications on multiple myeloma and plasma cell dyscrasias.

To provide the highest quality of care, interpreter services may be utilized to ensure proper communication of medical information for deaf, hard-of-hearing, and non-English speaking patients or family members.